Literature DB >> 15655048

Patient concerns regarding chronic hepatitis C infections.

G Y Minuk1, A Gutkin, S G Wong, K D E Kaita.   

Abstract

Counselling of patients with chronic hepatitis C infections is often limited to discussions regarding how the virus is transmitted and what can be done to decrease the risk of transmission to others. The purpose of the present study was to document the principal concerns of newly diagnosed and follow-up patients with chronic hepatitis C, and thereby enhance counselling strategies and content. Seventy newly diagnosed and 115 follow-up patients with chronic hepatitis C virus (HCV) infection were initially asked in an open-ended manner (volunteered concerns) and then to prioritize from a prepared list of seven potential concerns (prioritized concerns), to identify those concerns that were of utmost importance to them. The most common volunteered concerns of newly diagnosed patients in decreasing order were: disease progression (27%), premature death (19%), infecting family members (13%), side-effects of treatment (11%) and miscellaneous others. In decreasing order, prioritized concerns included: infecting family members, development of liver cancer, infecting others, development of cirrhosis, social stigma of having liver disease, need for liver transplant and loss of employment. The principal volunteered and prioritized concerns of follow-up patients were similar to those of newly diagnosed patients. Volunteered and prioritized concerns were relatively consistent across the different genders, age groups, ethnic backgrounds, education level, marital status, employment, modes of viral acquisition and in the case of follow-up patients, duration of follow-up. These results indicate that health care providers who focus counselling efforts exclusively on viral transmission are unlikely to address other important concerns of newly diagnosed and follow-up patients with chronic HCV infection.

Entities:  

Mesh:

Year:  2005        PMID: 15655048     DOI: 10.1111/j.1365-2893.2005.00553.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

1.  Mental and physical symptoms associated with lower social support for patients with hepatitis C.

Authors:  Julie A Blasiole; Laura Shinkunas; Douglas R Labrecque; Robert M Arnold; Susan L Zickmund
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 2.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

Review 3.  Quality of life in cirrhosis.

Authors:  Anthony Loria; Carey Escheik; N Lynn Gerber; Zobair M Younossi
Journal:  Curr Gastroenterol Rep       Date:  2013-01

4.  Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself.

Authors:  Edna Strauss; Francisco Augusto Porto-Ferreira; Cesar de Almeida-Neto; Maria Cristina Dias Teixeira
Journal:  Clin Res Hepatol Gastroenterol       Date:  2013-11-14       Impact factor: 2.947

5.  Formal patient education improves patient knowledge of hepatitis C in vulnerable populations.

Authors:  Miranda Surjadi; Cara Torruellas; Claudia Ayala; Hal F Yee; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2010-10-24       Impact factor: 3.199

6.  Knowledge of HBV and HCV and individuals' attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan.

Authors:  Hisashi Eguchi; Koji Wada
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

Review 7.  Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease.

Authors:  Patricia C Valery; Elizabeth Powell; Neta Moses; Michael L Volk; Steven M McPhail; Paul J Clark; Jennifer Martin
Journal:  BMJ Open       Date:  2015-04-08       Impact factor: 2.692

8.  Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis.

Authors:  Hamish Innes; Alex J Walker; Jennifer Benselin; Jane I Grove; Vincent Pedergnana; M Azim Ansari; Shang-Kuan Lin; John McLauchlan; Sharon J Hutchinson; Eleanor Barnes; William L Irving; Indra Neil Guha
Journal:  Clin Transl Gastroenterol       Date:  2022-02-09       Impact factor: 4.396

9.  Health-related quality of life among blood donors with hepatitis B and hepatitis C: longitudinal study before and after diagnosis.

Authors:  Francisco Augusto Porto Ferreira; Cesar de Almeida-Neto; Maria Cristina Dias Teixeira; Edna Strauss
Journal:  Rev Bras Hematol Hemoter       Date:  2015-09-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.